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osting by EAbstract Introduction: Renal artery stenosis (RAS) is one of the leading causes of secondary
hypertension, and can result in refractory hypertension or ischemic renal failure. RAS is present
in 0.5–5% of all hypertensive patients. It became even more important to diagnose it in the time
of intervention. Direct Angiography is the Gold Standard for evaluation of renal artery stenosis
and severity. It cannot be used as a screening test because of its invasiveness, high cost and use
of nephrotoxic gents. Different non invasive techniques have evolved for the evaluation of renal
artery including; captopril renography, computed tomography (CT) angiography, magnetic reso-
nance (MR) angiography and ultrasound (US) Doppler. Recently, the advent of CE 3D MRA
appears to be a new promising approach.
Purpose: To evaluate the diagnostic value of both contrast enhanced magnetic resonance angiog-
raphy (CE MRA) and phase contrast MRA (PC MRA) techniques in cases of renal artery stenosis
as compared to conventional angiography.
Methods and materials: Thirty patients (22 males and 8 females), with mean age 37 years (range 23–
72 years). All with suspected renal artery stenosis were evaluated using both CE MRA and PC
MRA techniques. All were subsequently subjected to conventional renal angiography..com (S.H. Omar).
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60 Y. Ragab et al.Results: CE MRA alone compared to direct Angiography (Gold standard) had a 91% sensitivity
and 87% speciﬁcity. PC MRA had overall 50% sensitivity and 25% speciﬁcity. PC MRA alone was
unable to differentiate mild stenosis from normal and could not distinguish severe stenosis from
total occlusion. Combining both MRA techniques yielded 100% speciﬁcity 94% positive and
100% negative predictive values.
Conclusion: The combined approach of non-invasive CE MRA and PC MRA techniques achieves
a very high speciﬁcity, PPV and NPV for the detection of renal arterial pathomorphologic features
as compared to standard renal angiography. Adding PC MRA to CE MRA helps to differentiate
between mild and moderate stenoses as well as moderate and sever arterial stenotic lesions. So, CE
MRA is a morphological test while PC MRA helps in grading the arterial stenoses.
ª 2011 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The incidence of RAS is about 0.1% in the general population,
4.0% in a hypertensive population, and 10–20% in individuals
with hypertension and CAD.1–4 For patients with peripheral
vascular disease, the prevalence of atherosclerotic RAS has
been estimated to be 30–50% in most studies.5 Overall, ische-
mic nephropathy may be responsible for 5–22% of advanced
renal disease in patients older than 50 years.
There has been considerable debate regarding the value of
routine renal arteriography at the time of coronary arteriogra-
phy. In the largest series of patients undergoing such screening,
1235 unselected, consecutive patients had both coronary arte-
riography and abdominal aortography.3 Thirty percent of pa-
tients had some evidence of atherosclerotic RAS and 15% had
lesions with P50% diameter stenosis.
2. Material and methods
Patients with either abrupt onset of severe hypertension or any
degree of hypertension under the age of 25 or above 50 years
were usually scanned for the possible presence of renal artery
stenosis as a cause of secondary hypertension. Only cases sub-
jected to direct renal angiography were subjected to comple-
mentary MRA studies. Those with suspected lesion with
initial MRA were subsequently subjected to direct angiogra-
phy. A total of 30 patients were included who had the two
modalities done.
All patients were subjected to the following:
* Full history taking, including onset and duration of hyper-
tension and drug intake. History suggestive of complication
(cerebrovascular, cardiac, peripheral, vascular, and renal)
and family history of hypertension.
* Complete clinical examination, including measurement of
blood pressure at three different occasions, measurement
of blood pressure in tile lower limb, signs of endocrinal dis-
eases, fundus examination, cardiac size, auscultation over
the aortic area and auscultation of renal angles.
* ECG: for left axis deviation, left atrial or ventricular
enlargement, strain pattern and ischemic changes.
* Laboratory investigations including:
 Fasting and 2-h post prandial blood sugar levels. Blood urea nitrogen and creatinine.
 Na and K blood levels.
s 24-h urinary catecholamines. 24-h urinary cortisol.
 Complete urine analysis.Any patient with any of the following exclusion criteria was
excluded from the study:
 Detection of any endocrinal cause of secondary hyperten-
sion such as; pheochromocytoma, Conn’s disease, Cushing
syndrome or acromegaly.
 Pregnancy.
 Creatinine level > 1.5 mg/dl.
Thirty patients; 22 males and 8 females, their ages ranging
from 23 to 72 years, with suspected renal artery stenosis were
evaluated by both contrast enhanced magnetic resonant angi-
ography (CE MRA) with 3D MIP reconstruction. Phase con-
trast magnetic resonant angiography (PC MRA) techniques.
Nineteen patients had subsequent conventional angiography
(CA), while one patient with known history of severe allergy
to iodinated contrast media, was examined by duplex ultraso-
nography of the renal arteries. Patients were examined by a
superconducting ITesla magnet (Magneton expert).
An anteroposterior phased array surface coil was used for
signal reception in conjunction with standard receivers. The
coil was placed to cover the expected volume containing the re-
nal arteries and the abdominal aorta.
To prevent aliasing, patients were imaged with their arms
placed on cushions that elevated them above the abdomen.
Following sagittal localizer ORE sequence, a bolus of
contrast medium, gadolinium DTPA is injected via a 20-
gauge needle placed in the antecubital fossa. A dose of
0.2 mmol/kg body weight was injected by an automatic
injector. In our study, the time delay is empirically deter-
mined on basis of the patient’s age and the cardiovascular
status. Typically, a delay of 10 s between the start of injec-
tion and the start of imaging works in the majority of pa-
tients when the scan time is 16 s.
We used SPGR T1 weighted sequence for scanning the re-
gion of interest twice.
The parameters used are:
Table 1 Clinical and laboratory data of the studied patients.
Parameter Number of patients (%)
Duration of hypertension
>1 year 13 (45%)
<1 year 17 (55%)
Blood pressure grade (diastolic)
Grade I (91–104) 3 (10%)
Grade II (105–114) 12 (40%)
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TE: 2.2 mes.
Flip tingle: 30
Partition: 24
Matrix: 150 · 256
Field of view: 350 mm
No. of acquisitions or NEX: I
Scan time: 16 sGrade III (115–125) 15 (50%)
Family history
+ve 21(70%)
ve 9 (30%)
Drug intake
Diuretics 18 (60%)
B-Blockers 8 (25%)
ACE inhibitors 10 (35%)
CCB 14 (50%)
ARB 12 (40%)
Others 6 (20%)
Diabetic mellitus
+ve 5 (16%)
ve 25 (84%)
Complications
IHD 9 (30%)
LVE 10 (35%)
TIAs 6 (20%)This will be followed by axial 3D phase contrast MRA of
the renal arteries.
The parameters used are:
TR: 94 mes.
TE: 11 mes.
Flip angle: 12
Slap thickness: 48
Velocity encoding: 50 cm/s (30 cm/s in cases with heart or renal
failure)
Partitions: 24
Matrix: 160 · 256
FOV: 300
No. of acquisitions: I
Scan time: 3.34 minBruit over renal angles
+ve 3 (10%)
ve 25 (90%)
Fundus examination
Normal 22 (75%)
Exudates & hemorrhage 6 (20%)
Papilloedema 1 (3%)
ECG
Normal 20 (66%)
Abnormal 10 (33%)Post processing was done after the techniques using maxi-
mal intensity projection (MIP).
3. Results
Thirty patients, 22 males and 8 females, were included in the
study. Four patients were below the age of 25 years (mean
21.5 years), 12 patients were above the age of 50 years (mean
62.8 years), and 14 patients were between 30 and 50 years
(mean 43.1 years). Their clinical and laboratory data are illus-
trated in the Table 1.
Notes:
 One case with moderate stenosis was overestimated as
severe one by CE MRA due to improper window setting.
 One case with mild renal arterial stenosis was overlooked by
CEMRA due to overlapping renal vein.
Thirty patients (60 renal arteries) were evaluated by both
MRA techniques (contrast enhanced MRA and 3D phase
contrast).
Twenty-nine patients had undergone conventional angiog-
raphy as Gold standard technique. One patient was examined
by Doppler ultrasonography due to known history of severe
allergy to iodinated contrast medium.
Table 2 demonstrates the CE MRA ﬁndings in cases sus-
pected clinically to have renal arterial stenosis, with reference
to conventional renal angiography.
There were ﬁve patients with severe arterial stenosis
(>75% narrowing) detected. One case was evaluated as severe
stenosis traced on CE MRA, yet the corresponding CA
showed it as a moderate one. This error was attributed to
imaging at narrow window setting.So, four cases graded as moderate stenosis based on CE
MRA, out of ﬁve moderate stenosis with reference to Gold
standard technique (CA).
Eight cases out of nine were graded as mild stenosis when
CE MRA results were compared with CA. One case with mild
ostial stenosis was overlooked due to overlapping by the ipsi-
lateral renal vein (mild delay in acquisition after contrast
administration).
One normal case was detected in both CE MRA and CA
(kidney donor with incidentally detected hypertension).
Table 3 correlates the phase contrast (PC) ﬁndings with ref-
erence to CA. The 5 patients with moderate stenosis on basis
of CA show mild narrowing on PC. While the nine patients
with mild stenosis appeared normal on PC MRA images.
The seven patients with severe stenosis on basis of CA,
showed total occlusion in PC MRA images denoting marked
spine dephasing.3.1. Comparing the CE MRA with the PC MRA ﬁndings
The 14 patients with normal or mildly stenosed renal arteries
based on CE MRA showed normal appearances on PC MRA.
Eight patients were evaluated as having moderate stenosis
by PC MRA, while six patients showed evidence of moderate
Table 2 CE MRA ﬁndings of our patients compared to direct CA.
Grade Gr by direct angio By CE MRA How seen By CE MRA
Normal 2 4 2 normal and 2 from the mild group (venous contamination hindering proper assessment)
Mild 12 10 All from mild and 2 categorized in normal
Moderate 8 6 2 were dropped as they were estimated as severe due to motion artifact
Severe 7 9 7 already severe with another 2 moderate estimated as severe due to motion artifact
Table 3 3D PC MRA Findings of our patients compared to
direct CA.
Grade By direct angio By PC MRA Comment
Normal 2 14 2 normal + 12 mild
seen normal
Mild 12 0 All cases of mild lesion
appeared normal
Moderate 8 8
Severe 7 7
62 Y. Ragab et al.stenosis by CE MRA (one patient was overestimated due to
improper window setting).
Out of nine patients with severe stenosis on basis of CE
MRA, only seven patients showed total occlusion by PC
MRA (the severe stenosis caused marked spine, dephasing
on PC MRA).
The last case with history of severe allergy to contrast med-
ium was evaluated by Doppler ultrasound and well compared
with CE MRA and PC MRA diagnoses as moderate stenosis.
The results of CE MRA alone when compared with CA
(Gold Standard) were 95% sensitivity and 90% speciﬁcity,
while the results of PC MRA were 50% sensitivity and 25%
speciﬁcity. However, it was 100% sensitivity and speciﬁcity
in cases of moderate stenosis. (The PC MRA can not differen-
tiate between mild stenosis and normal arteries, nor distinguish
between severe stenosis from total occlusion).Figure 1A Contrast enhanced MRA showing seIf results of both CE MRA and PC MRA are combined to-
gether, for each patient, the sensitivity and speciﬁcity will be
almost 100%.
Figs. 1 and 2 show two examples of our cases showing how
the two MRA techniques are complementary to each other.
3.2. Case 1
In Case 1 (Fig. 1A and B) contrast enhanced MRA showed se-
vere proximal focal left renal arterial stenosis which was con-
ﬁrmed by phase contrast technique.
3.3. Case 2
While in case 2 the lesion which was seen as severe narrowing
by Contrast Enhanced technique was found to be of moderate
severity on using the Phase Contrast technique as seen in
Fig. 2A and B.
4. Discussion
A speciﬁc cause of hypertension can be established in only 10–
15% of cases. However, the patients should not be ignored,
since correction of these causes may cure their hypertension.6
Hypertension is both a cause and a consequence of renal dis-
ease, and irrespective of etiology, hypertension is a major
determinant of renal disease progression.7 Primary renal
parenchymal disease has been observed to be responsible forvere proximal focal left renal arterial stenosis.
Figure 1B Phase contrast MRA. SIGNAL loss of the left renal artery denoting tight stenosis.
Non invasive assessment of renal artery using dual MRA techniques compared with invasive renal 633–4% of hypertension, and renovascular disease in around
1%.8
Screening for renal artery stenosis (RAS) should be re-
stricted to patients with a high RAS risk. Captopril renog-
raphy, computed tomography (CT)-angiography, magnetic
resonance (MR)-angiography and ultrasound (US) Doppler
can be used. Most patients should receive medical treat-
ment. If predictive tests suggest a good outcome, revascu-
larisation with percutaneous transluminal renal angioplasty
(PTRA) should be considered in patients with refractory
hypertension, ﬁbromuscular dysplasia, recurrent pulmonary
oedema, bilateral renal artery stenosis or progressive azota-
emia, and in patients with a narrow stenosis to a single
kidney.9
A variety of different imaging techniques have been used
for the diagnosis of renal vascular diseases. The wide range
of renal vascular diseases include congenital renal artery and
vein variations, aneurysms, arteriovenous malformations
(AVMs), renal artery stenosis, renal vein thrombosis, vasculi-
tis, and traumatic injuries, such as dissection and vascular ped-
icle injury. In this article, we discuss the role of invasive and
noninvasive imaging in each of these abnormalities and their
typical features. Because renal artery stenosis is an important
vascular abnormality encountered in clinical practice, imaging
of this entity will be emphasized.10
The renal angiogram is the standard test to establish both
the presence of a renal artery lesion and aids in the determina-
tion of whether the lesion is due to atherosclerosis or to one of
the ﬁbrosis or ﬁbromuscular dysplasias.11
Contrast enhanced 3D MR angiography is a useful alterna-
tive in the assessment of pathomorphological feature of the re-
nal arteries. Reliable detection of signiﬁcant stenosis isachieved with both high sensitivity and speciﬁcity, provided
that careful attention is given to the technique.
This fact stands in contrast to that associated with PC
MRA technique which depends on the inherent motion sensi-
tivity of the MR experiment to selectively depict ﬂow.12
Furthermore, arterial blood is depicted solely on basis of
the presence of paramagnetic contrast medium within it. So,
proper timing of data acquisition assures a high quality angio-
gram free of venous enhancement.
In our study, one case was missed and overlooked. This was
most likely due to overlapping by the Tenatvein, i.e. imperfect
acquisition of central lines of K-space data. According to Jef-
frey Weinreb, there are four different approaches for timing
breath-hold CE MRA’s.13
(1) Timing dose:
Delay = circulation time + infusion time  1/2 imag-
ing time).
1–2 cc Gd is injected, and scanning is repeated at the
level of interest.
 This can be simpliﬁed by making the infusion ti-
me = imaging time.
 This technique can be implemented in any
scanner.
(2) Automated contrast detection (Smart prep on GE).
(3) Fluorosscoping triggering.
(4) Time resolved scan.
In our study, the time delay is empirically determined on
the basis of the patient’s age and the cardiovascular status.
Typically a delay of 10 s between the start of injection and
Figure 2A Contrast enhanced MRA showing an (apparently) tight proximal Rt. Renal artery stenosis.
Figure 2B Phase contrast MRA and angiogram proved the same stenosis to be of moderate degree.
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16 s data acquisition is used. This technique was previously de-
scribed by Dong et al. in 1999.14
Another pitfall met with in our study using CE MRA was
over estimation of moderate stenosis due to imaging at a nar-
row window setting. This pitfall was described by Dong et al.
in 1999.14
Other pitfalls described with the use of CE MRA are failure
to suspend breathing, inadequate dose of gadolinium contrast
material, and artifacts of surgical clip or arterial stents.14 They
stated also that eccentric disease may be identiﬁed on only one
view, thus, it is important to look at renal arteries on multiple
views.
The high sensitivity and speciﬁcity of CE MRA have been
documented in the studies of Steffens (1997), who reported96% and 95%, in the study of De Cobelli (1996) 100% and
97% and in Bakker (1999) 97% and 92% sensitivity and spec-
iﬁcity, respectively.15–17
The 3D PC imaging commonly demonstrates artiﬁcial spine
dephasing at the renal artery origins. This has been particu-
larly described with severe and occasionally moderate
stenosis.14
Also, choosing the phase encoding velocity is occasionally
problematic particularly in patients with poor cardiac output,
renal insufﬁciency or aortic aneurysm.18
Although 3D CE MRA provides a high sensitivity and
speciﬁcity in morphologic assessment of the arterial lumen,
yet it is not sufﬁcient for complete evaluation in patients sus-
pected to have renal artery stenosis. It is necessary to evaluate
the hemodynamic signiﬁcance of such stenosis.
Non invasive assessment of renal artery using dual MRA techniques compared with invasive renal 65Adding data obtained from 3D PCMRA to those identiﬁed
by CEMRA, functional assessment of renal arterial stenosis
becomes feasible. Mild stenosis detected by CE MRA can be
differentiated from moderate ones on basis of the PC MRA
which reﬂects normal ﬂow status in the former group (mild ste-
nosis). 3D PC MRA can differentiate between moderate and
severe stenosis identiﬁed by CE MRA. Severe spine dephasing
simulating total arterial occlusion will be detected in the latter
group (severe stenosis), while in moderate stenosis in CEMRA
will also show similar degree of narrowing in the PC MRA.
This is the suggested protocol for screening of patients sus-
pected to have renal arterial stenosis.
Recent data on the appropriateness of renal imaging were
published by the American college of cardiology.19
5. Conclusion
Duplex ultrasonography is a good screening test in many pa-
tients, but it has limitations in larger persons and can overlook
small accessory arteries. For patients with normal renal func-
tion but a high clinical index of suspicion for renovascular dis-
ease, contrast-enhanced magnetic resonance angiography and
computed tomographic angiography are the most accurate
imaging tests. For patients with diminished renal function,
gadolinium-enhanced contrast magnetic resonance angiogra-
phy is the best imaging test. However, caution is warranted be-
cause exposure to gadolinium contrast agents is associated
with nephrogenic systemic ﬁbrosis in patients with renal fail-
ure. The American College of Radiology has developed appro-
priateness criteria for imaging tests related to the diagnosis of
renal artery stenosis.20
It is concluded that combined CE MRA and 3D PC MRA
techniques are useful in the assessment of pathomorphological
features of the renal arteries.
Reliable detection of signiﬁcant stenosis is achieved with
both high sensitivity and speciﬁcity, provided that careful
attention is given to the techniques.
The combined approach of using techniques is a very useful
non invasive modality for assessment of renal artery in cases of
suspected renovascular pathology as an etiology to the
hypertension.
CE MRA has a poorer ability to grade the degree of nar-
rowing which can be overcome by re-looking at the PC pic-
tures to properly estimate the functional signiﬁcance of the
narrowing.
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